(Q44520594)

3 December 2017

title

5-aryl thiazolidine-2,4-diones: discovery of PPAR dual alpha/gamma agonists as antidiabetic agents (English)

1 reference

3 December 2017

Ranjit C Desai

1

1 reference

3 December 2017

Wei Han

2

1 reference

3 December 2017

Edward J Metzger

3

1 reference

3 December 2017

Jeffrey P Bergman

4

1 reference

3 December 2017

Dominick F Gratale

5

1 reference

3 December 2017

Karen L MacNaul

6

1 reference

3 December 2017

Joel P Berger

7

1 reference

3 December 2017

Thomas W Doebber

8

1 reference

3 December 2017

Kwan Leung

9

1 reference

3 December 2017

David E Moller

10

1 reference

3 December 2017

James V Heck

11

1 reference

3 December 2017

Soumya P Sahoo

12

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

3 December 2017

published in

1 reference

3 December 2017

volume

13

1 reference

3 December 2017

issue

16

1 reference

3 December 2017

page(s)

2795-2798

1 reference

Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Peroxisome proliferator-activated receptor gamma and the control of adipogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Conclusions from the VA-HIT study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

Amphipathic 3-phenyl-7-propylbenzisoxazoles; human pPaR gamma, delta and alpha agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900505-5

7 January 2021

10.1016/S0960-894X(03)00505-5

Identifiers

DOI

1 reference

3 December 2017

1 reference